SCHEMBL2066946

SCHEMBL2066946

CCCc1ccc2nc(C(=O)OCC)c(S(=O)(=O)Cl)n2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.43
MAPT P10636 5/20 0.36
NPC1 O15118 4/20 0.36
HSD17B10 Q99714 2/20 0.36
ALDH1A1 P00352 2/20 0.36
TP53 P04637 1/20 0.36
XBP1 P17861 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TLR9 Q9NR96 1/20 0.36
TARBP2 Q15633 2/20 0.36
GLP1R P43220 1/20 0.36
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
RAB9A P51151 3/20 0.35
ELANE P08246 3/20 0.35
KDM4E B2RXH2 1/20 0.35
F2 P00734 1/20 0.35
PLAU P00749 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2068560 0.89 PDE4A (0.43) PDE4AMAPTNPC1HSD17B10ALDH1A1
SCHEMBL2067668 0.85 PDE10A (0.33) PDE4APDE10A
SCHEMBL2828650 0.81 PDE4A (0.46) PDE4AMAPTNPC1HSD17B10ALDH1A1
SCHEMBL2066260 0.80 PDE10A (0.38) HSD17B10KDM4EPDE10A
SCHEMBL2066273 0.78 PDE4A (0.67) PDE4AMAPTNPC1HSD17B10ALDH1A1
SCHEMBL2067045 0.77 PDE10A (0.31) PDE10A
SCHEMBL2065623 0.77 PDE10A (0.31) PDE10A
SCHEMBL2065990 0.77 JAK1 (0.32) NPC1TP53RAB9AKDM4ESMN1; SMN2
SCHEMBL2066641 0.77 PDE10A (0.30) PDE10A
SCHEMBL2066142 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148524-B2 Process for producing sulfonyl chloride compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-04-03 US disclosed
US-20090247748-A1 PROCESS FOR PRODUCING SULFONYL CHLORIDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247748-A1 PROCESS FOR PRODUCING SULFONYL CHLORIDE COMPOUND SALL4, CLCN2, CLIC1 PDE4A 4317/4885MAPT 4701/4885NPC1 2888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.